Reactualisation of hormonal treatment at the menopause in 2011;Réactualisation du traitement hormonal à la ménopause en 2011

Revue Medicale de Bruxelles

Volumn 32, Issue 4, 2011, Pages 239-242

  Rozenberg, S ^a   Vandromme, J ^a   Antoine, C ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Breast cancer; Cardiovascular; Climacteric; Hormone therapy; Menopause; Osteoporosis

Indexed keywords

CALCIUM; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; VITAMIN D;

AGE; BREAST CANCER; CANCER RISK; CORONARY ARTERY DISEASE; HORMONAL THERAPY; HUMAN; MENOPAUSE; MENOPAUSE HORMONE THERAPY; MONOTHERAPY; OSTEOPOROSIS; REVIEW; RISK REDUCTION; STROKE; THROMBOEMBOLISM;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CLIMACTERIC; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 80053909846     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Rossouw JE, Anderson GL, Prentice RL et al.; Writing Group for the Women's Health Initiative Investigators : Risks and benefits of estrogen plus progestin in healthy postmenopausal women : principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288 : 321-33 (Pubitemid 34761611)
2. Chlebowski RT, Hendrix SL, Langer RD; WHI Investigators : Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women : the Women's Health Initiative Randomized Trial. JAMA 2003; 289 : 3243-53 (Pubitemid 37430077)
3. Beral V; Million Women Study Collaborators : Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362 : 419-27
4. Gompel A, Rozenberg S, Barlow DH; EMAS board members : The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy. Maturitas 2008; 61 : 227-32
5. Body JJ, Bergmann P, Boonen S et al. : Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis : a consensus document by the Belgian Bone Club. Osteoporos Int 2010; 21 : 1657-80
6. Lambrinoudaki I, Brincat M, Erel CT et al. : EMAS position statement : managing obese postmenopausal women. Maturitas 2010; 66 : 323-6
7. Tremollieres F, Brincat M, Erel CT et al. : EMAS position statement : Managing menopausal women with a personal or family history of VTE. Maturitas 2011; 69 : 195-8
8. Rozenberg S : New therapeutic targets and agents for osteoporosis. Maturitas 2010; 65 : 299-300
9. La Croix AZ, Chlebowski RT, Manson JE et al.; WHI Investigators : Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy : a randomized controlled trial. JAMA 2011; 305 : 1305-14
10. Fournier A, Berrino F, Clavel-Chapelon F : Unequal risks for breast cancer associated with different hormone replacement therapies : results from the E3N cohort study. Breast Cancer Res Treat 2008; 107 : 103-11 (Pubitemid 350179584)